EMJ Oncology 10 [Supplement 8] . 2022

Journal Info

EMJ had the pleasure of interviewing two leading specialists within the field of oncology and oesophageal cancer, Zachary Wilmer Reichenbach, Department of Gastroenterology, Section of Medicine, and the Center for Substance Abuse Research (CSAR), Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA, and Elizabeth Smyth, Cambridge University Hospitals NHS Foundation Trust, UK. The experts shared their perspectives on the treatment landscape of oesophageal cancer.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?